Drug Trial Radar · NCT00541047
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
Last checked: Nov 19, 2026Latest source record: Nov 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,236
Actual
Start
Nov 2007
Primary completion
Jul 27, 2022
Study completion Jul 27, 2022
Sponsor
- Lead sponsor
- University College, LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Canadian Cancer Trials Group
- First posted
- Oct 8, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 0 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy, such as goserelin, leuprolide, or bicalutamide, may lessen the amount of androgens made by the body. Giving radiation therapy together with androgen deprivation therapy may kill more prostate cancer cells. PURPOSE: This randomized phase III trial is studying how well giving radiation therapy together with androgen deprivation therapy works in treating patients who have undergone surgery for prostate cancer.
Conditions
- Gastrointestinal Complications
- Prostate Cancer
- Sexual Dysfunction
- Urinary Complications
Interventions
bicalutamideDrug
goserelin acetateDrug
leuprolide acetateDrug
adjuvant therapyProcedure
quality-of-life assessmentProcedure
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-specific survival (i.e., death due to prostate cancer) (RADICALS-HD)Time frame: up 12 years
- Freedom from distant metastases (any distance metastases or prostate cancer death) (RADICALS-RT)Time frame: up 12 years
Locations
58 sites in 2 countries. Site status is shown where the registry gives one.
British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
Ottawa Health Research Institute
Ottawa, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
William Harvey Hospital
Ashford, England, United Kingdom
North Devon District Hospital
Barnstaple, England, United Kingdom
Basingstoke and North Hampshire NHS Foundation Trust
Basingstoke, England, United Kingdom
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust
Birmingham, England, United Kingdom
Royal Bournemouth Hospital
Bournemouth, England, United Kingdom
Bradford Royal Infirmary
Bradford, England, United Kingdom
Southmead Hospital
Bristol, England, United Kingdom
Bristol Haematology and Oncology Centre
Bristol, England, United Kingdom
Addenbrooke's Hospital
Cambridge, England, United Kingdom
Kent and Canterbury Hospital
Canterbury, England, United Kingdom
Walsgrave Hospital
Coventry, England, United Kingdom
Mid Cheshire Hospitals Trust- Leighton Hopsital
Crewe, England, United Kingdom
Mayday University Hospital
Croydon, England, United Kingdom
Doncaster Royal Infirmary
Doncaster, England, United Kingdom
Dorset County Hospital
Dorchester, England, United Kingdom
Royal Devon and Exeter Hospital
Exeter, England, United Kingdom
St. Luke's Cancer Centre at Royal Surrey County Hospital
Guildford, England, United Kingdom
Princess Alexandra Hospital
Harlow, England, United Kingdom
Ipswich Hospital
Ipswich, England, United Kingdom
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, United Kingdom
Lincoln County Hospital
Lincoln, England, United Kingdom
Helen Rollason Cancer Care Centre at North Middlesex Hospital
London, England, United Kingdom
University College Hospital
London, England, United Kingdom
Guy's Hospital
London, England, United Kingdom
Royal Marsden - London
London, England, United Kingdom
Maidstone Hospital
Maidstone, England, United Kingdom
Clatterbridge Centre for Oncology
Manchester, England, United Kingdom
Christie Hospital
Manchester, England, United Kingdom
James Cook University Hospital
Middlesbrough, England, United Kingdom
Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Derriford Hospital
Plymouth, England, United Kingdom
Dorset Cancer Centre
Poole Dorset, England, United Kingdom
Queen's Hospital
Romford, England, United Kingdom
Rotherham General Hospital
Rotherham, England, United Kingdom
Hope Hospital
Salford, England, United Kingdom
Showing 40 of 58 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.